The presence of insulin antibodies may increase or decrease the efficacy of insulin and may require dose adjustment.Rapid improvement in glucose control has been associated with a transitory, reversible ophthalmologic refraction disorder and worsening of Rapid improvement in glucose control has been associated with a transitory, reversible acute painful peripheral neuropathy. In the ORIGIN trial, the median change in body weight from baseline to the last treatment visit was 2.2 kg greater in the insulin glargine group (+1.4 kg vs -0.8 kg).Injection site reactions include redness, pain, itching, hives, swelling, or inflammation. Toujeo SoloStar (insulin glargine)." Although not all of these side effects may occur, if they do occur they may need medical attention. Low blood potassium may happen with this medicine (Lantus).
"Product Information. You may report them to the The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. ([2011 Jan 12]):Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.Some side effects may not be reported. "Product Information. In some cases, these reactions may be caused by other factors, such as irritants in skin cleansing agents. Available for Android and iOS devices.We comply with the HONcode standard for trustworthy health information - Eli Lilly Canada Inc, Toronto, ON.
Very low blood sugar can lead to seizures, passing out, long lasting brain damage, and sometimes death. The detection of antibody formation is highly dependent on the sensitivity and specificity of the assay and may be influenced by assay methodology, sample handling and collection, concomitant medications, and underlying disease. Available for Android and iOS devices.We comply with the HONcode standard for trustworthy health information - U.S. Food and Drug Administration "FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer.
Available from: URL: http://www.fda.gov/Drugs/DrugSafety/ucm239376.htm." These include: Allergic reaction to Lantus. "Product Information. Although not all of these side effects may occur, if they do occur they may need medical attention.Some side effects of ethambutol may occur that usually Check with your health care professional if any of the following side effects The most commonly reported side effects included decreased visual acuity and 1. Check with your doctor immediately if any of the following side effects occur while taking ethambutol: Less common. If not treated, this can lead to a heartbeat that is not normal, very bad breathing problems, and sometimes death. O 02. Myambutol (ethambutol)." Basaglar (insulin glargine)." In July 2009, The US FDA reported on an ongoing safety review evaluating a possible increased risk of cancer. You may report them to the The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Talk with the doctor. sanofi-aventis, Bridgewater, NJ. O 02. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.Some side effects may not be reported. Along with its needed effects, ethambutol (the active ingredient contained in Myambutol) may cause some unwanted effects. O 03. 4. Hypoglycemia has been reported with a sudden change to an unaffected injection site.Hypersensitivity side effects have included both local and systemic reactions. Lederle Laboratories, Wayne, NJ. FDA. However, long-term glycemic control decreases the risk.1. O 03. In February 2011, the FDA in an updated communication reported the evidence was inconclusive and it is not possible to conclude that the use of this insulin increases the risk of cancer.As with all therapeutic proteins, the potential for immunogenicity exits.